In:
Obstetrical & Gynecological Survey, Ovid Technologies (Wolters Kluwer Health), Vol. 77, No. 2 ( 2022-2), p. 96-97
Abstract:
(Abstracted from JCO Glob Oncol 2021;7:1032–1066) The lack of reliable screening modalities for ovarian cancer results in most women being diagnosed on the basis of symptomatic presentation with the majority at advanced stages. Nonspecific symptoms may be overlooked or misdiagnosed regardless of how resource-rich the health care system.
Type of Medium:
Online Resource
ISSN:
1533-9866
,
0029-7828
DOI:
10.1097/OGX.0000000000001007
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2022
detail.hit.zdb_id:
2043471-6